JAGUAR HEALTH, INC. Stock Issued During Period, Shares, Restricted Stock Award, Gross
JAGUAR HEALTH, INC. (JAGX) had Stock Issued During Period, Shares, Restricted Stock Award, Gross of 13.31 thousand shares as of 2017-07-03, per its 10-Q filed 2017-11-20.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2018-04-09
- 2017-07-03: Stock Issued During Period, Shares, Restricted Stock Award, Gross 13.31K shares.
- 2016-01-01: Stock Issued During Period, Shares, Restricted Stock Award, Gross 17.55K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross |
|---|---|
| 2017-07-03 | 13.31K shares 10-Q · filed 2017-11-20 |
| 2016-01-01 | 17.55K shares 10-K · filed 2018-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |